Statistical flags indicate unusual patterns — not proof of fraud or wrongdoing. Read our methodology

#738 of 11K

J1428

Eteplirsen (Exondys 51) injection, 10 mg

Eteplirsen (Exondys 51) injection, 10 mg is the #738 most-billed Medicaid procedure code, with $92.3M in payments across 4K claims from 2018–2024. The national median cost per claim is $20,923.17.

Total Paid

$92.3M

0.01% of all spending

Total Claims

4K

Providers

1

Avg Cost/Claim

$21K

National Cost Distribution

How much do providers bill per claim for J1428? Based on 1 providers billing this code nationally.

Median

$20,923.17

Average

$20,923.17

Std Dev

Max

$20,923.17

Percentile Distribution (Cost per Claim)

p10
$20,923.17
p25
$20,923.17
Median
$20,923.17
p75
$20,923.17
p90
$20,923.17
p95
$20,923.17
p99
$20,923.17

50% of providers bill between $20,923.17 and $20,923.17 per claim for this code.

90% bill between $20,923.17 and $20,923.17.

Top 1% bill above $20,923.17.

About This Procedure

HCPCS code J1428 (Eteplirsen (Exondys 51) injection, 10 mg) was billed by 1 providers across 4K claims, totaling $92.3M in Medicaid payments from 2018–2024. This code was used for 915 unique beneficiaries.

Fraud Risk Context

Injectable drug codes carry high per-claim costs and have been involved in drug diversion and upcoding schemes.

Source: HHS OIG Reports

Risk Assessment

Billing Statistics

Median Cost/Claim

$20,923.17

Providers Billing

1

National Spending

$92.3M

Avg/Median Ratio

1.00×

Normal distribution

Provider Coverage

We have 1 providers billing this code in our dataset. Individual provider breakdowns are available for top-spending procedure codes.